Skip to main
SI
SI logo

SI Stock Forecast & Price Target

SI Analyst Ratings

Based on 5 analyst ratings
Strong Buy
Strong Buy 60%
Buy 40%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Shoulder Innovations Inc. demonstrated strong financial performance in 2Q25, reporting total revenue of $11.8 million, a 58% increase that surpassed previous estimates by $1.8 million. The company benefitted from higher-than-anticipated average selling prices (ASPs) due to favorable product mix, contributing to a positive outlook for sustainable revenue growth. With an improved balance sheet and an increasing number of surgeon adopters of their implant systems, Shoulder Innovations is well-positioned for ongoing expansion in the shoulder surgical care market.

Bears say

Shoulder Innovations Inc. reported a significant adjusted EBITDA loss of $7.5 million, which exceeded prior projections by approximately $400,000, highlighting financial challenges. The company faces multiple risks, including a slower-than-expected uptake of its products among new surgeons, lower growth rates in the shoulder market, and higher-than-anticipated operating expenses, all contributing to a negative outlook. Additionally, the firm recorded a total EBITDA loss of $35.9 million, compounded by increased selling, general, and administrative expenses due to higher headcount and legal costs.

SI has been analyzed by 5 analysts, with a consensus rating of Strong Buy. 60% of analysts recommend a Strong Buy, 40% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Silvergate Capital Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Silvergate Capital Corp (SI) Forecast

Analysts have given SI a Strong Buy based on their latest research and market trends.

According to 5 analysts, SI has a Strong Buy consensus rating as of Nov 27, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $19.60, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $19.60, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Silvergate Capital Corp (SI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.